Evidence map›Paper›PMID 26365511›Full record

ArticleStem cell reports2015

Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes.

Tsunao Kishida, Akika Ejima, Kenta Yamamoto, Seiji Tanaka, Toshiro Yamamoto, Osam Mazda

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Studying Brown Adipose Tissue in a HumanFrontiers in endocrinology · 2020
    Review
  17. Article
  18. Review
  19. Ectopic brown adipose tissue formation within skeletal muscle after brown adipose progenitor cell transplant augments energy expenditure.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  20. Brown Adipose Tissue Development and Metabolism.Handbook of experimental pharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tsunao KishidaDepartment of Immunology, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan.
Akika EjimaDepartment of Immunology, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan.
Kenta YamamotoDepartment of Immunology, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan; Department of Dental Medicine, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan.
Seiji TanakaDepartment of Immunology, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan.
Toshiro YamamotoDepartment of Dental Medicine, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan.
Osam MazdaDepartment of Immunology, Kyoto Prefectural University of Medicine, Kamikyo, Kyoto 602-8566, Japan. Electronic address: mazda@koto.kpu-m.ac.jp.
Kyoto Prefectural University of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown adipocytes (BAs) play important roles in body temperature regulation, energy balance, and carbohydrate and lipid metabolism. Activities of BAs are remarkably diminished in obese and diabetic patients, providing possibilities of transplanting functional BAs resulting in therapeutic benefit. Here, we show generation of functional BAs by cellular reprogramming procedures. Transduction of the PRDM16 gene into iPSC-derived embryoid bodies induced BA phenotypes (iBAs). Moreover, normal human fibroblasts were directly converted into BAs (dBAs) by C/EBP-β and C-MYC gene transduction. Approximately 90% of the fibroblasts were successfully converted within 12 days. The dBAs were highly active in mitochondrial biogenesis and oxidative metabolism. Mouse dBAs were induced by Prdm16, C/ebp-β, and L-myc genes, and after transplantation, they significantly reduced diet-induced obesity and insulin resistance in an UCP1-dependent manner. Thus, highly functional BAs can be generated by cellular reprogramming, suggesting a promising tailor-made cell therapy against metabolic disorders including type 2 diabetes mellitus.

Indexed as

Cellular ReprogrammingInsulin ResistanceAdipocytes, BrownAnimalsCell LineDiabetes Mellitus, Type 2Diet, High-FatDNA-Binding ProteinsDyslipidemiasFibroblastsHumansInduced Pluripotent Stem CellsMaleMiceMice, Inbred C57BLObesityDNA-Binding ProteinsPRDM16 protein, humanTranscription Factors

Identifiers

PMID26365511
PMCPMC4624936
OpenAlexW1905155763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.